Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Podolec, J. Siekaniec (Cracow, Poland). Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB. Eur Respir J 2011; 38: Suppl. 55, 835

Member's Comments

No comment yet.

Related content which might interest you: Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Evaluation of pulmonary diffusion: TLCO or KCO? Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Comparison between SCOT-15® and Perfadex® as lung preservation solutions Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler® Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler® Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Transcutaneous measurement of pCO2 (ptcCO2): Time delay from change in alveolar pCO2 to first response in ptcCO2 Source: Annual Congress 2011 - Sleep and weight: heavy under pressure Year: 2011 Endogenous particles in exhaled air – Variability of particle number in healthy individuals Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Ways to shorten the lung clearance index measurement ΙΙ – How long to wash? Source: Annual Congress 2012 - New developments in paediatric respiratory physiology Year: 2012 Effective and efficient nebulization of alpha1-proteinase inhibitor (alpha1-PI) for inhalation therapy using the AKITA2® APIXNEBÔ nebulizer system Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010 Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Study of the use of Chartis® pulmonary assessment system to optimize subject selection for endobronchial lung volume reduction (ELVR) – Results and subgroup analysis Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 Evaluation of a new motion sensor in patients with COPD – Preliminary results Source: Annual Congress 2010 - Physical activity methodology assessment and clinical consequences Year: 2010 The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention Source: Annual Congress 2011 - Medical education Year: 2011 The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010